$10.880
0.000 (0.00%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de DMAA por análisis de gráficos similares
Alphio's DMAA stock price prediction model matches the current Drugs Made In America Acquisition Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.85 (-0.32%). The 1-week path is $11.02 (+1.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Drugs Made In America Acquisition Corp?
Currently, DMAA is trading at $10.89, which is 97.5% of its 52-week high of $10.90. The RSI is at 59.42, indicating the asset is nearing overbought territory, which suggests caution. While the stock has shown a year-to-date change of +4.87%, the forward P/E is 0, indicating a lack of earnings growth expectations. The main risk is the current ratio of 0.02, suggesting potential liquidity issues.
DMAA cerró en $10.88 el Wednesday, tras subir 0.00%
Drugs Made In America Acquisition Corp (DMAA) last closed at $10.8800001, gaining +0.00%. These facts feed the 1-day and 1-week DMAA price prediction above.
Factores de la previsión
Los factores de la previsión de Drugs Made In America Acquisition Corp (DMAA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de DMAA, ordenadas por similitud.
Análisis de estacionalidad de DMAA
Historically the probability of a positive November return for DMAA is 100.00%. April offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de DMAA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $9.61 | $11.80 | $13.16 | +8.45% |
| Dec 2026 | $9.57 | $9.82 | $10.91 | -9.73% |
En 2026, se proyecta que Drugs Made In America Acquisition Corp (DMAA) oscile entre $9.57 y $13.16.
Previsión mensual de Drugs Made In America Acquisition Corp para 2026
En Nov de 2026, se proyecta que Drugs Made In America Acquisition Corp promedie $11.80, con un mínimo de $9.61 y un máximo de $13.16.
En Dec de 2026, se proyecta que Drugs Made In America Acquisition Corp promedie $9.82, con un mínimo de $9.57 y un máximo de $10.91.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.